PD-1 and PD-L2 expression predict relapse risk and poor survival in patients with stage III colorectal cancer.

Mehmet Zengin Sema Zergeroğlu Oguzhan Okcu Suat Benek

Published in: Cellular oncology (Dordrecht) (2021)

Our data indicate that PD-1 and PD-L2 may serve as independent prognostic survival parameters for CRC patients and may be employed for the design of targeted therapies.

Keyphrases

end stage renal disease
free survival
chronic kidney disease
ejection fraction
newly diagnosed
big data
machine learning
deep learning